Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Average approval time reduced by 2.5-3.5 years. Breakthrough therapy designation usually increases valuation significantly. Takeover offers typically increase with breakthrough therapy designations.
AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the US for adult patients with HER2-positive early breast cancer ...
Ellen Sigal, the founder of the patient advocacy group Friends of Cancer Research (FOCR), is a self-described accidental tourist in the world of drug discovery. After completing a PhD in Russian ...
Earn all 3 medals on Bloon Circles map Bloon Circles Olympian Earn all 3 medals on Bloons Of Clubs map Bloons Of Clubs Olympian Earn all 3 medals on Bloontonium Lab map Bloontonium Lab Olympian Earn ...
A trailer released for the game that’s shown above previews some of the monkey and Adventure Time characters that’ll be in the free mobile game along with the customization options that let players ...
Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the Company, and co-developed with JMT-Bio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback